miRview® mets² and miRview® mets are cutting-edge molecular diagnostic tests that use microRNAs to identify the tissue-of-origin of tumors. The test offers unsurpassed accuracy, specificity, and sensitivity.

In the majority of cases, miRview® mets² and miRview® mets return a single tissue prediction with:

• 90% sensitivity¹ 

1. Data on file, Rosetta Genomics.